BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Hippocampus
,
Pharmacogenetics
,
Cisplatin
,
rs2476601
,
BRCA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
peroxisome proliferator- activated receptor delta
Summary
General Info
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Livers of Wild-Type and PPARalpha-Null Mice Exposed to Perfluorooctanoic Acid (PFOA)
Peroxisome proliferator-activated receptor beta (PPARb) overexpression in skeletal muscle
Myotubes cultured in a PPARdelta agonist
Hepatocytes treated with PPARd agonists KD3010 and GW1516
Explore Curated Studies Results
Literature
Most Relevant Literature
PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass.
Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR…
Design and Structural Optimization of Dual FXR/PPARδ Activators.
Single Nucleotide Polymorphisms in PPARD Associated with Systemic Lupus Erythematosus in Chinese Pop…
Novel Cinnamic Acid Derivatives as Potential PPARδ Agonists for Metabolic Syndrome: Design, Synthesi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndr…
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Exten…
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatri…
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Heal…
A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ